Found: 14
Select item for more details and to access through your institution.
Population Pharmacokinetics of Belimumab Following Intravenous Administration in Patients With Systemic Lupus Erythematosus.
- Published in:
- Journal of Clinical Pharmacology, 2013, v. 53, n. 7, p. 711, doi. 10.1002/jcph.104
- By:
- Publication type:
- Article
Population Pharmacokinetics and Exposure-Response of Albinterferon Alfa-2b.
- Published in:
- Journal of Clinical Pharmacology, 2012, v. 52, n. 4, p. 475, doi. 10.1177/0091270011399576
- By:
- Publication type:
- Article
Selection of a Ligand-Binding Neutralizing Antibody Assay for Benralizumab: Comparison with an Antibody-Dependent Cell-Mediated Cytotoxicity (ADCC) Cell-Based Assay.
- Published in:
- AAPS Journal, 2018, v. 20, n. 3, p. 1, doi. 10.1208/s12248-018-0207-8
- By:
- Publication type:
- Article
Population Pharmacokinetics and Exposure–Response Analysis of Tremelimumab 300 mg Single Dose Combined with Durvalumab 1500 mg Q4W (STRIDE) in Patients with Unresectable Hepatocellular Carcinoma.
- Published in:
- Journal of Clinical Pharmacology, 2023, v. 63, n. 11, p. 1221, doi. 10.1002/jcph.2288
- By:
- Publication type:
- Article
Safety, Pharmacokinetics, and Antiviral Activity of HGSOO4, a Novel Fully Human IgG4 Monoclonal Antibody against CCR5, in H1V-1—Infected Patients.
- Published in:
- Journal of Infectious Diseases, 2008, v. 197, n. 5, p. 721, doi. 10.1086/527327
- By:
- Publication type:
- Article
Safety, Tolerability and Pharmacokinetics of Half-Life Extended Severe Acute Respiratory Syndrome Coronavirus 2 Neutralizing Monoclonal Antibodies AZD7442 (Tixagevimab-Cilgavimab) in Healthy Adults.
- Published in:
- Journal of Infectious Diseases, 2023, v. 227, n. 10, p. 1153, doi. 10.1093/infdis/jiad014
- By:
- Publication type:
- Article
Population Pharmacokinetics and Exposure–Response Analysis for the CTLA‐4 Inhibitor Tremelimumab in Metastatic NSCLC Patients in the Phase III POSEIDON Study.
- Published in:
- Clinical Pharmacology & Therapeutics, 2023, v. 114, n. 6, p. 1375, doi. 10.1002/cpt.3063
- By:
- Publication type:
- Article
Bacillus anthracis Protective Antigen Kinetics in Inhalation Spore-Challenged Untreated or Levofloxacin/ Raxibacumab-Treated New Zealand White Rabbits.
- Published in:
- Toxins, 2013, v. 5, n. 1, p. 120, doi. 10.3390/toxins5010120
- By:
- Publication type:
- Article
Development of a long-acting insulin analog using albumin fusion technology.
- Published in:
- 2005
- By:
- Publication type:
- journal article
Population pharmacokinetic modelling of tremelimumab in patients with advanced solid tumours and the impact of disease status on time‐varying clearance.
- Published in:
- British Journal of Clinical Pharmacology, 2023, v. 89, n. 5, p. 1601, doi. 10.1111/bcp.15622
- By:
- Publication type:
- Article
Safety, Tolerability, and Pharmacokinetics of Benralizumab: A Phase 1, Randomized, Single-Blind Study of Healthy Chinese Participants.
- Published in:
- Drug Design, Development & Therapy, 2023, v. 17, p. 209, doi. 10.2147/DDDT.S392155
- By:
- Publication type:
- Article
An integrated functional genomics screening program reveals a role for BMP-9 in glucose homeostasis.
- Published in:
- Nature Biotechnology, 2003, v. 21, n. 3, p. 294, doi. 10.1038/nbt795
- By:
- Publication type:
- Article
TIP, a T-cell factor identified using high-throughput screening increases survival in a graft-versus-host disease model.
- Published in:
- Nature Biotechnology, 2003, v. 21, n. 3, p. 302, doi. 10.1038/nbt797
- By:
- Publication type:
- Article
Association Between Leukocyte Telomere Length and Vascular Dementia and Cancer Mortality in an Elderly Population.
- Published in:
- Journal of the American Geriatrics Society, 2014, v. 62, n. 7, p. 1384, doi. 10.1111/jgs.12910
- By:
- Publication type:
- Article